The government plans to implement the use of "e-labels" for certain biopharmaceutical products, including the newly developed antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and the anti-PD-1 immunotherapy Keytruda (pembrolizumab).Last Friday, the Ministry of Food and Drug Safety anno
The last day of February every year is “World Rare Disease Day.” People who decided it reportedly thought about the rarity of February, the last day of which ends on the 29th every four years, to symbolize the experiences of people with rare diseases. Korea had celebrated it on May 24 until last yea
A Korean research team, led by Professor Kim Na-young at the Department of Internal Medicine of Seoul National University Bundang Hospital (SNUBH), analyzed the differences between males and females with stomach cancer positive for the Epstein-Barr virus (EBV), which infects more than 90 percent of
In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) have emerged as a groundbreaking third generation of treatment, drawing global attention as a promising sector. These software-based interventions, designed to treat diseases and enhance health much like traditional pharmace
Kakao Healthcare said over 50 health regulatory officials, including those from the Ministry of Food and Drug Safety, the WHO, and the U.S. FDA, visited its headquarters on Monday in light of the AI Regulatory and International Symposium 2024 (AIRIS 2024).The event is ongoing at the Shilla Seoul Hot
CHA Biotech has launched a study to enhance the anticancer efficacy of its natural killer (NK) cell therapeutic drug by making the most of polymer, a cationic compound.The cationic compounds used in the study are synthetic polymers, in which monomers, molecules with low molecular weight, are repeate
The government has released a draft of the “Special Act on Handling of Medical Accidents" to appease the medical community, which has been protesting against the increase in medical school students.However, it remains to be seen whether the proposed law will be enacted, as the timeline for its imple
A Severance Hospital research team has revealed that a hemostatic powder made from plant extracts significantly improves the success rate of initial hemostasis in patients with gastrointestinal bleeding caused by peptic ulcers.Peptic ulcers, which result from the digestive acid eroding the lining of
Professor Keum Ki-chang of radiation oncology at Yonsei University College of Medicine has been appointed as CEO and President of Yonsei University Health System (YUHS) and YUHS Vice President for Health Sciences, Severance Hospital said on Tuesday. His term will begin on March 1 and will last for f
The government has concluded that the recent death of a cardiac arrest patient in her 80s in Daejeon while being transported by ambulance was not related to "emergency rooms’ refusal to accept patients.”The Ministry of Health and Welfare said Tuesday that it reached such a conclusion after conductin
BeiGene, a global biotech firm founded in 2010 in Beijing, is strengthening its global presence by expanding its workforce and boosting sales.The company is waiting for the U.S. Food and Drug Administration (FDA) to approve its anti-PD-1 immuno-oncology drug Tevimbra (tislelizumab) this year, drawin
Starting next month, biliary tract cancer patients can add the anti-PD-L1 immunotherapy Imfinzi (durvalumab) at their own expense to the existing gemcitabine/cisplatin (GemCis) chemotherapy regimen for the first-line treatment of locally progressive or metastatic biliary tract cancer.It was part of
CG Bio said it has become the largest shareholder in Innosys, a research and manufacturing company focused on orthopedic implants, following the completion of an equity acquisition on Tuesday.The acquisition involved CG Bio finalizing share transfer agreements for a 17.75 percent stake in Innosys an
The Ministry of Food and Drug Safety has signed a mutual recognition agreement (MRA) with Singapore's Health Sciences Authority (HSA) to recognize the results of Good Manufacturing Practice (GMP) surveys of pharmaceutical manufacturing facilities between the two countries.Minister of Food and Drug S
A research team at CHA Bundang Medical Center has developed a promising solution for male infertility, particularly for patients suffering from Klinefelter syndrome.Klinefelter syndrome, characterized by the presence of an extra X chromosome (XXY instead of the typical XY), is the most common cause
Roche Korea hosted a two-day RISE (Roche Initiated Scientific Exchange) symposium on Thursday and Friday last week, shedding light on the clinical significance of the pioneering bispecific antibodies for blood cancer, Columvi (ingredient: glofitamap) and Lunsumio (mosunetuzumab).Comprising five sess
Pharos iBio will collaborate with the team of Professor Shin Sang-joon of the Department of Medical Oncology at Yonsei Cancer Center to conduct the translational study of PHI-501 under development for treating solid tumors.PHI-501 is a pipeline of solid tumor therapeutics in preclinical development.
Medytox has encountered a significant setback as the U.S. FDA has declined the biologics license application (BLA) for its innovative non-animal liquid botulinum toxin product, MT10109L, aimed at reducing moderate to severe glabellar (forehead) and lateral canthal (crow's feet) lines.The refusal, da
AriBio said Monday that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has formally approved POLARIS-AD, a global phase 3 clinical trial of AR1001, an oral treatment for Alzheimer's disease.AriBio plans to initiate the phase 3 trial in the U.K. before the end of the first quarte
The Korean government has made a formal proposal to the nation's medical community, urging them to appoint representative members to engage in discussions on critical issues such as the expansion of medical school quotas and the cessation of ongoing collective actions, including strikes and mass res